Alibaba's increase expanded to 6%, JPMorgan Chase's new position in WuXi Biologics

Wall Street giants are reviewing investment opportunities in China. JPMorgan has newly established positions in Alibaba and WuXi Biologics (76.95, 7.00, 10.01%), and increased its holdings in JD; In the first quarter, Bridgewater Associates continued to increase its holdings of Chinese shares such as Alibaba, Pinduoduo and Baidu.
$JPMorgan(JPM.US)$ $Brigewater Holdings(BK2122.US)$ $Alibaba(BABA.US)$ $BABA-SW(09988.HK)$ $WUXI BIOLGCS ADR(WXXWY.US)$ $WUXI BIO(02269.HK)$ $Baidu(BIDU.US)$ $BIDU-SW(09888.HK)$ $JD.com(JD.US)$ $JD-SW(09618.HK)$ $PDD Holdings(PDD.US)$ $Pinduoduo Concept(BK0724.SH)$